Skip to content

Clinical trials

Hypertension, Pulmonary trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension, Pulmonary Country / region: Netherlands Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20022
20031
20041
20062
20082
20093
20104
20112
20122
20131
20142
20151
20163
20171
20182
20193
20201
20212
20221
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Terminated8
Unknown status2
Enrolling by invitation2
Recruiting2
No longer available1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
United Therapeutics6
Bayer5
Novartis Pharmaceuticals4
University Medical Center Groningen4
Actelion3
GlaxoSmithKline3
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.3
Biogen2
Abbott Medical Devices1
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension, Pulmonary42
Pulmonary Arterial Hypertension16
Cardiovascular Diseases4
Heart Failure3
Lung Diseases3
Vascular Diseases3
Connective Tissue Diseases2
Familial Primary Pulmonary Hypertension2
Hypertension2
Respiratory Tract Diseases2

Trials

Showing 26 to 42 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.